Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-26

Clinical Trial Update: Biperiden Trial for Epilepsy Prevention [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating biperiden for epilepsy prevention in moderate to severe traumatic brain injury and post-traumatic epilepsy is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biperiden (biperiden)

Snippet

Sponsor: Hospital Sirio-Libanes | Conditions: Brain Injury Traumatic Moderate, Brain Injury Traumatic Severe | Phase 3 | Status: RECRUITING